Coronary disease & ACS

Variability in Cardiac Stress Test Interpretation: Agreement Between Enrollment Sites and Core Laboratories in the Global ISCHEMIA Trial

Circ Popul Health OutcomesPublished randomized trial

Authors' conclusion

In ISCHEMIA, enrollment sites frequently overestimated or underestimated the severity of myocardial ischemia compared with core laboratory assessments, highlighting the need for strategies to improve the consistency and accuracy of stress testing interpretation in patients with chronic coronary disease.

Study context

Population
Participants in the ISCHEMIA trial with chronic coronary disease and moderate or severe ischemia, with site-interpreted qualifying stress tests (nuclear, echo, cardiac magnetic resonance, or exercise tolerance test) and independent core laboratory adjudicationmean age, 62.8 years, 73% men
Participants
6,971 participants
Comparison
Site-determined ischemia levels compared to standardized core lab assessments
Methodological detailsglobal (37 countries, 2012-2018), core laboratories, serving as the reference standard, reinterpreted tests blinded to site results, adjusted mixed-effects logistic regression models with random site intercepts
  • Global (37 countries, 2012-2018)
  • Core laboratories, serving as the reference standard, reinterpreted tests blinded to site results
  • Adjusted mixed-effects logistic regression models with random site intercepts

Primary result

As reported in the abstract

Ischemia severity classification

Moderate

Severe

OutcomeEnrollment sitesCore laboratories
No/mild (by design)0%— not stated in the abstract
None— not stated in the abstract8%
Mild— not stated in the abstract11%

— not stated in the abstract

Further findings

Site overestimation (adjusted median odds ratio)

Adjusted median odds ratio (95% CI)
Enrollment sitesNuclear2.36 (2.02–2.82)
Enrollment sitesEcho1.98 (1.62–2.60)
Enrollment sitesCardiac magnetic resonance1.89 (1.0–5.41)
Enrollment sitesExercise tolerance test2.15 (1.76–2.79)

Site-core lab agreement, imaging modalities

Median site-core lab agreement rates
≈55%
Site-classified moderate/severe cases downgraded to no or mild ischemia by core labs
nearly 25%

Site underestimation (adjusted median odds ratio)

Adjusted median odds ratios for underestimation ranged from
1.25 to 1.77

Original publication

Variability in Cardiac Stress Test Interpretation: Agreement Between Enrollment Sites and Core Laboratories in the Global ISCHEMIA Trial. Circ Popul Health Outcomes. Published 1 July 2026. doi:10.1161/circoutcomes.125.012920

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.